All Type of News
Two drug makers sanctioned over non-compliance of process validation
The Korea Food and Drug Administration says it discovered two local pharmaceutical companies that failed to comply with the current GMP (current good manufacturing practice) standards.
According to the drug agency,...
Controversy grows over HIRAS president resignation
The Health Insurance Review Assessment and Service confirmed on January 25 that its president Song Jae-sung expressed his will to resign to the Ministry of Health and Welfare due to unidentified reason.
The decisio...
KFDA approves Micardis for hypertension
The Korea Food and Drug Administration said on January 22 that it has approved the supplemental indication of Micardis (telmisartan), an angiotensin II receptor blocker (ARB), for reduction of the risk of myocardial i...
Bayer Healthcare to start ADVISE study
Bayer Healthcare said it will conduct its phase 4 study entitled “Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension” in the Asia-Pacific region.”
For ...
7 functional health foods to delist from food compendium
A total of seven functional health foods, including mushrooms, royal jelly, pollen, enzyme products, yeast products and plant extract, will be delisted from the official food compendiums, according to the Food and Dru...
Minister Yoon urges deregulation on pharmacy business
Korea's finance minister said Korea should overhaul the business licensing system ― any person now, for example, can open a pharmacy as long as he or she hires a pharmacist.
In a press interview with a local paper ...
KFDA warns possible cardiovascular events over 56 anti-obesity drugs
Over 56 drug companies marketing anti-obesity drug sibutramine under a variety of brand names are likely to soon face a ban on selling the medicine.
The Korea Food and Drug Administration will initiate steps to asc...
Yuyu to release natural antidepressant agent
Yuyu Pharm said it will St. John’s wort extract (brand name: Noiromin) containing its active ingredient hyperforin at pharmacy from next month.
According to the company, hyperforin exhibits significant antidepressa...
Additional indication approved for Nexium
The Korea Food and Drug Administration said it has approved additional indication of AstraZeneca’s Nexium (esomeprazole) – prevention of duodenal re-hemorrhage after endoscopic treatment (Nexium injection and maintena...
Hanmi introduce RFID system on pharmaceutical products
Hanmi Pharm said it has started to supply all of 300 drugs using the Radio Frequency Identification (RFID) service last December.
Hanmi said it is the first time that a local pharmaceutical manufacturer has used th...
